Dimethylformamide → HCID 22720322, 화합물

반응식

P(Cl)(Cl)(Cl)=O.[CH2:6]1[C:12]2=[CH:13][C:14]3[CH:15]=[CH:16][CH:17]=[CH:18][C:19]=3[N:11]2[CH2:10][CH2:9][N:8]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:7]1.CN([CH:30]=[O:31])C>>[CH:30]([C:13]1[C:14]2[CH:15]=[CH:16][CH:17]=[CH:18][C:19]=2[N:11]2[CH2:10][CH2:9][N:8]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:7][CH2:6][C:12]=12)=[O:31]

참가 물질

반응물 3

HCID 6228Dimethylformamide2회

HCID 24813Phosphorus oxychloride

HCID 9835548HCID 9835548, 화합물

생성물 1

HCID 22720322HCID 22720322, 화합물

실험 절차

A solution of DMF (10 mL) cooled to 0° C. is treated with phosphorus oxychloride (0.30 mL, 3.3 mmol) and stirred for 10 min. This clear colorless solution of the cloroiminium salt is slowly treated with a solution of tert-butyl 1,2,4,5-tetrahydro-3H-[1,4]diazepino[1,7-a]indole-3-carboxylate in DMF (9 mL) followed by warming to rt. After 18 hr, the reaction is quenched with 5N sodium hydroxide (40 mL), stirred 5 min, and extracted twice with dichloromethane (40 mL). The combined organics are washed twice with water (25 mL), once with brine (25 mL), dried over MgSO4, filtered, and concentrated to give 942 mg of a crude yellow solid. This material is purified by LC (biotage 40 g column) eluting with 35% ethyl acetate/heptane to afford 677 mg of tert-butyl 11-formyl-1,2,4,5-tetrahydro-3H-[1,4]diazepino[1,7-a]indole-3-carboxylate as a pale yellow solid, mp 167-168° C. IR (drift) 1684, 1654, 1469, 1424, 1396, 1370, 1350, 1304, 1248, 1197, 1170, 1121, 762, 757, 752 cm−1.